Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 34

1.

Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MR-HIFU): Overview of Emerging Applications (Part 2).

Siedek F, Yeo SY, Heijman E, Grinstein O, Bratke G, Heneweer C, Puesken M, Persigehl T, Maintz D, GrĂ¼ll H.

Rofo. 2019 Jan 10. doi: 10.1055/a-0817-5686. [Epub ahead of print]

2.

PTV margin analysis for prostate patients treated with initial pelvic nodal IMRT and prostate proton boost.

Su Z, Li Z, Henderson R, Hoppe BS, Nichols RC, Bryant C, Mendenhall W, Mendenhall N.

Phys Med Biol. 2019 Jan 10. doi: 10.1088/1361-6560/aafd75. [Epub ahead of print]

PMID:
30630135
3.

Slow component apparent diffusion coefficient for prostate cancer: Comparison and correlation with pharmacokinetic evaluation from dynamic contrast-enhanced MR imaging.

Ogura A, Maeda F, Yahata S, Koyama D, Tsunoda F, Hayashi N, Motegi S, Yamamura K.

Magn Reson Imaging. 2019 Jan 7;58:14-17. doi: 10.1016/j.mri.2019.01.003. [Epub ahead of print]

PMID:
30630069
4.

In vitro cytotoxicity and interaction of noscapine with human serum albumin: Effect on structure and esterase activity of HSA.

Maurya N, Maurya JK, Singh UK, Dohare R, Zafaryab M, Rizvi MMA, Alanazi AM, Khan AA, Kumari M, Patel R.

Mol Pharm. 2019 Jan 10. doi: 10.1021/acs.molpharmaceut.8b00864. [Epub ahead of print]

PMID:
30629454
5.

Discovery of ARD-69 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Androgen Receptor (AR) for the Treatment of Prostate Cancer.

Han X, Wang C, Qin C, Xiang W, Fernandez-Salas E, Yang CY, Wang M, Zhao L, Xu T, Chinnaswamy K, Delproposto J, Stuckey J, Wang S.

J Med Chem. 2019 Jan 10. doi: 10.1021/acs.jmedchem.8b01631. [Epub ahead of print]

PMID:
30629437
6.

Antiproliferative Cardenolides from the Aerial Parts of Pergularia tomentosa.

Hosseini SH, Masullo M, Cerulli A, Martucciello S, Ayyari M, Pizza C, Piacente S.

J Nat Prod. 2019 Jan 10. doi: 10.1021/acs.jnatprod.8b00630. [Epub ahead of print]

PMID:
30629433
7.

Population net benefit of prostate MRI with high spatiotemporal resolution contrast-enhanced imaging: A decision curve analysis.

Prabhu V, Rosenkrantz AB, Otazo R, Sodickson DK, Kang SK.

J Magn Reson Imaging. 2019 Jan 10. doi: 10.1002/jmri.26318. [Epub ahead of print]

PMID:
30629317
8.

Genome-wide analysis of ETV1 targets: Insights into the role of ETV1 in tumor progression.

Eid W, Abdel-Rehim W.

J Cell Biochem. 2019 Jan 10. doi: 10.1002/jcb.28169. [Epub ahead of print]

PMID:
30629294
9.

Association of Patient Comorbid Conditions With Cancer Clinical Trial Participation.

Unger JM, Hershman DL, Fleury ME, Vaidya R.

JAMA Oncol. 2019 Jan 10. doi: 10.1001/jamaoncol.2018.5953. [Epub ahead of print]

PMID:
30629092
10.

Immunohistochemistry Use by Diagnostic Category and Pathologist in 4477 Prostate Core Biopsy Sets Assessed at Two Hospitals.

Bonert M, El-Shinnawy I, Rahman M, Major P, Salama S, Shayegan B, Cutz JC, Kapoor A.

Appl Immunohistochem Mol Morphol. 2019 Jan 8. doi: 10.1097/PAI.0000000000000726. [Epub ahead of print]

PMID:
30628979
11.

Polycomb Group Proteins EZH2 and EED Directly Regulate Androgen Receptor in Advanced Prostate Cancer.

Liu Q, Wang G, Li Q, Jiang W, Kim JS, Wang R, Zhu S, Wang X, Yan L, Yi Y, Zhang L, Meng Q, Li C, Zhao D, Qiao Y, Li Y, Gursel DB, Chinnaiyan AM, Chen K, Cao Q.

Int J Cancer. 2019 Jan 10. doi: 10.1002/ijc.32118. [Epub ahead of print]

PMID:
30628724
12.

The role of negative magnetic resonance imaging: can we safely avoid biopsy in P.I.-R.A.D.S. 2 as in P.I.-R.A.D.S. 1?

Regis L, Celma A, Planas J, Lopez R, Roche S, Lorente D, Placer J, Trilla E, Morote J.

Scand J Urol. 2019 Jan 10:1-5. doi: 10.1080/21681805.2018.1551243. [Epub ahead of print]

PMID:
30628520
13.

Non-invasive Serum Metabolomic Profiling Reveals Elevated Kynurenine Pathway's Metabolites in Humans with Prostate Cancer.

Khan A, Choi SA, Na J, Pamungkas AD, Jung KJ, Jee SH, Park YH.

J Proteome Res. 2019 Jan 10. doi: 10.1021/acs.jproteome.8b00803. [Epub ahead of print]

PMID:
30628444
14.

Sarcosine is a prostate epigenetic modifier that elicits aberrant methylation patterns through the SAMe-Dnmts axis.

Strmiska V, Michalek P, Lackova Z, Guran R, Krizkova S, Vanickova L, Zitka O, Stiborova M, Eckschlager T, Klejdus B, Pacik D, Tvrdikova E, Keil C, Haase H, Adam V, Heger Z.

Mol Oncol. 2019 Jan 9. doi: 10.1002/1878-0261.12439. [Epub ahead of print]

15.

The Histone Demethylase UTX/KDM6A in Cancer: Progress and Puzzles.

Schulz WA, Lang A, Koch J, Greife A.

Int J Cancer. 2019 Jan 10. doi: 10.1002/ijc.32116. [Epub ahead of print] Review.

PMID:
30628063
16.

Problems sleeping with prostate cancer: exploring possible risk factors for sleep disturbance in a population-based sample of survivors.

Maguire R, Drummond FJ, Hanly P, Gavin A, Sharp L.

Support Care Cancer. 2019 Jan 9. doi: 10.1007/s00520-018-4633-z. [Epub ahead of print]

PMID:
30627919
17.

MicroRNA Expression Profiles Identify Biomarker for Differentiating the Embolic Stroke from Thrombotic Stroke.

Chen LT, Jiang CY.

Biomed Res Int. 2018 Dec 6;2018:4514178. doi: 10.1155/2018/4514178. eCollection 2018.

18.

Effect of Neoadjuvant Hormone Therapy on Resection Margin and Survival Prognoses in Locally Advanced Prostate Cancer after Prostatectomy Using Propensity-Score Matching.

Kim SH, Park EY, Joo J, Joung JY, Seo HK, Chung J, Lee KH.

Biomed Res Int. 2018 Dec 6;2018:4307207. doi: 10.1155/2018/4307207. eCollection 2018.

19.

A real-world study assessing the use of bone-targeted agents and their impact on bone metastases in patients with prostate cancer treated in clinical practice in Europe.

Body JJ, von Moos R, Rider A, Hallworth P, Bhowmik D, Gatta F, Hechmati G, Qian Y.

J Bone Oncol. 2018 Dec 18;14:100212. doi: 10.1016/j.jbo.2018.100212. eCollection 2019 Feb.

20.

ESTIMATING AND COMPARING CANCER PROGRESSION RISKS UNDER VARYING SURVEILLANCE PROTOCOLS.

Lange JM, Gulati R, Leonardson AS, Lin DW, Newcomb LF, Trock BJ, Carter HB, Cooperberg MR, Cowan JE, Klotz LH, Etzioni R.

Ann Appl Stat. 2018 Sep;12(3):1773-1795. doi: 10.1214/17-AOAS1130. Epub 2018 Sep 11.

Supplemental Content

Loading ...
Support Center